BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//ChamberMaster//Event Calendar 2.0//EN
METHOD:PUBLISH
X-PUBLISHED-TTL:P3D
REFRESH-INTERVAL:P3D
CALSCALE:GREGORIAN
BEGIN:VEVENT
DTSTART:20230523T170000Z
DTEND:20230523T180000Z
X-MICROSOFT-CDO-ALLDAYEVENT:FALSE
SUMMARY:NIH: MORE THAN JUST FUNDING
DESCRIPTION:LEVERAGE THE NIH TO FUEL YOUR GROWTH\nHave you ever considered NIH as a contract research option? Have you ever considered licensing technology from NIH? NIH is more than just a funding source\, they can be a true partner in research and development.\n\n\n\nIn conjunction with state biotech associations in Colorado\, Arizona\, New Mexico and Montana\, BioUtah presents an opportunity to learn about NIH's role as a Technology Development and Commercialization Partner. The NIH is a resource that companies should consider to bolster their piplein or solve a development problem. Webinar participants will learn:  \n\n	How Technology commercialization and economic development are part of the NIH Mission. \n	That companies\, not just academia\, can partner with NIH \n	Success stories of how companies have worked with NIH \n	Next steps - points of contact\, partnering mechanisms\, licensing and more \n\n\n\n\n\nThe keynote speaker will be Dr. Michael Salgaller who leads the Technology Analysis and Marketing Unit (TAMU) within the National Institutes of Health (NIH's) Technology Transfer Center\, where he leverages over 20 years of business\, scientific\, and investment experience in various life science sectors to support technology development and commercialization. The TAMU serves in a business development role to foster licensing and collaborative activity between buy-side stakeholders and the NCI (as well as NIH in general). Immediately prior to returning to the NCI\, Michael was a vice president with a healthcare-focused government affairs firm\, where he led alliance development activities centered on civilian health. Michael spent several years on the investment team of an early-stage venture capital firm dedicated to the life sciences. He began his career as a Senior Scientist at the NCI. He is the author of "Biotechnology Entrepreneurship\," and teaches an entrepreneurship class at NIH. Dr. Salgaller received his Ph.D. in Pathology from The Ohio State University.
X-ALT-DESC;FMTTYPE=text/html:<h3 style="margin: 0px\; font-style: normal\; font-variant-caps: normal\; font-stretch: normal\; font-size: 16px\; line-height: normal\; font-family: Helvetica\; font-size-adjust: none\; font-kerning: auto\; font-variant-alternates: normal\; font-variant-ligatures: normal\; font-variant-numeric: normal\; font-variant-east-asian: normal\; font-variant-position: normal\; font-feature-settings: normal\; font-optical-sizing: auto\; font-variation-settings: normal\;">LEVERAGE THE NIH TO FUEL YOUR GROWTH</h3>\nHave you ever considered NIH as a contract research option? Have you ever considered licensing technology from NIH? NIH is more than just a funding source\, they can be a true partner in research and development.<br />\n<br />\nIn conjunction with state biotech associations in Colorado\, Arizona\, New Mexico and Montana\, BioUtah presents an opportunity to learn about NIH&#39\;s role as a Technology Development and Commercialization Partner. The NIH is a resource that companies should consider to bolster their piplein or solve a development problem. Webinar participants will learn: &nbsp\;\n<ul>\n	<li>How Technology commercialization and economic development are part of the NIH Mission.&nbsp\;</li>\n	<li>That companies\, not just academia\, can partner with NIH&nbsp\;</li>\n	<li>Success stories of how companies have worked with NIH&nbsp\;</li>\n	<li>Next steps - points of contact\, partnering mechanisms\, licensing and more&nbsp\;</li>\n</ul>\n<br />\n<img alt="" height="260" src="https://chambermaster.blob.core.windows.net/userfiles/UserFiles/chambers/9284/Image/Event_pics/Headshotsmall.JPG" style="width: 250px\; height: 260px\; margin: 20px\; float: left\;" width="250" /><br />\nThe keynote speaker will be Dr. Michael Salgaller who leads the Technology Analysis and Marketing Unit (TAMU) within the National Institutes of Health (NIH&rsquo\;s) Technology Transfer Center\, where he leverages over 20 years of business\, scientific\, and investment experience in various life science sectors to support technology development and commercialization. The TAMU serves in a business development role to foster licensing and collaborative activity between buy-side stakeholders and the NCI (as well as NIH in general). Immediately prior to returning to the NCI\, Michael was a vice president with a healthcare-focused government affairs firm\, where he led alliance development activities centered on civilian health. Michael spent several years on the investment team of an early-stage venture capital firm dedicated to the life sciences. He began his career as a Senior Scientist at the NCI. He is the author of &ldquo\;Biotechnology Entrepreneurship\,&rdquo\; and teaches an entrepreneurship class at NIH. Dr. Salgaller received his Ph.D. in Pathology from The Ohio State University.<br />\n<br />\n&nbsp\;
LOCATION:Zoom Webinar Link to join webinar will be provided prior to the event.
UID:e.9284.5573
SEQUENCE:3
DTSTAMP:20260408T154043Z
URL:http://devbioutah.memberzone.com/events/details/nih-more-than-just-funding-5573
END:VEVENT

END:VCALENDAR